Sarepta Therapeutics to Present Company Overview at the 2014 32nd Annual J.P.
Morgan Healthcare Conference
Webcast Accessible via Sarepta Therapeutics Website
CAMBRIDGE, MA -- (Marketwired) -- 12/19/13 -- Sarepta Therapeutics
(NASDAQ: SRPT), a developer of innovative RNA-based therapeutics,
announced today that it is scheduled to present at the 32nd Annual
J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday,
January 15, 2014 at 4:30 p.m. Pacific Time. Chris Garabedian,
Sarepta's president and chief executive officer, will be the
The presentations will be webcast live on the investor relations
section of the Sarepta Therapeutics website at www.sarepta.com and
will be archived under the events and presentations section following
the presentation for 90 days. Please connect to Sarepta's website
several minutes prior to the start of the broadcast to ensure
adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is focused on developing first-in-class
RNA-based therapeutics to improve and save the lives of people
affected by serious and life-threatening rare and infectious
diseases. The Company's diverse pipeline includes its lead program
eteplirsen, for Duchenne muscular dystrophy, as well as potential
treatments for some of the world's most lethal infectious diseases.
Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs.
For more information, please visit us at www.sarepta.com.
Sarepta Investor Contact:
Sarepta Media Contact:
Press spacebar to pause and continue. Press esc to stop.